Gene · 57045
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive proteomic profiling of urinary exosomes and the identification of early non-invasive biomarker in patients with coronary artery disease. | J Proteomics | 2024 | 38151158 | PubTator, text mining | PubMed |
| Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers. | Pathol Res Pract | 2024 | 38091885 | PubTator, text mining | PubMed |
| LINE-1 hypomethylation, increased retrotransposition and tumor-specific insertion in upper gastrointestinal cancer. | Cancer Sci | 2024 | 38013627 | PubTator, text mining | PubMed |
| Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma. | FEBS Open Bio | 2024 | 37964489 | PubTator, text mining | PubMed |
| Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens. | Life Sci Alliance | 2024 | 37863651 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. | Cancer Res Treat | 2024 | 37697729 | PubTator, text mining | PubMed |
| Vault RNAs (vtRNAs): Rediscovered non-coding RNAs with diverse physiological and pathological activities. | Genes Dis | 2024 | 37692527 | PubTator, text mining | PubMed |
| From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine. | Biomedicines | 2023 | 38275385 | PubTator, text mining | PubMed |
| A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail. | Natl J Maxillofac Surg | 2023 | 38273920 | PubTator, text mining | PubMed |
| Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways. | Int J Mol Sci | 2023 | 38203654 | PubTator, text mining | PubMed |
| Promising and Minimally Invasive Biomarkers: Targeting Melanoma. | Cells | 2023 | 38201222 | PubTator, text mining | PubMed |
| TSG-SLAM: SLAM Employing Tight Coupling of Instance Segmentation and Geometric Constraints in Complex Dynamic Environments. | Sensors (Basel) | 2023 | 38139653 | PubTator, text mining | PubMed |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. | Int J Mol Sci | 2023 | 38139431 | PubTator, text mining | PubMed |
| Susceptibility Genes Associated with Multiple Primary Cancers. | Cancers (Basel) | 2023 | 38136334 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. | Cell Discov | 2023 | 38114467 | PubTator, text mining | PubMed |
| Hepcidin and erythroferrone response to 3 weeks of exposure to normobaric hypoxia at rest in trained cyclists. | Front Physiol | 2023 | 38089475 | PubTator, text mining | PubMed |
| Pan-Cancer Profiling of Intron Retention and Its Clinical Significance in Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38067392 | PubTator, text mining | PubMed |
| Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067251 | PubTator, text mining | PubMed |
| Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. | Genome Med | 2023 | 38053165 | PubTator, text mining | PubMed |
| Association of APC Expression with Its Promoter Methylation Status and the Prognosis of Hepatocellular Carcinoma. | Asian Pac J Cancer Prev | 2023 | 38019243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57045/papers?page=5